Blood loss and transfusion associated with musculoskeletal tumor surgery

Akira Kawai, Hiroaki Kadota, Umio Yamaguchi, Yuki Morimoto, Toshihumi Ozaki, Yasuo Beppu

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background and Objectives: No organized data regarding the blood losses associated with musculoskeletal tumor surgery has been existed. The present study aimed to examine the extent of blood loss and the transfusion requirement associated with various kinds of musculoskeletal tumor surgeries in a large, well-defined sample. Methods: The records of 1,047 consecutive operations for musculoskeletal tumors were reviewed. Results: The total blood loss ranged from 0 to 26,050 ml (median: 95 ml). The operative time ranged from 5 to 1,140 min (median: 105 min). There was a significant correlation between the total blood loss and the operative time. The median blood loss was 10 ml in biopsies, 100 ml in curettages, 190 ml in amputations or disarticulations, 30 ml in marginal resections (bone tumors, 50 ml; soft tissue tumors, 25 ml), and 380 ml in wide resections (bone tumors, 2,155 ml; soft tissue tumors, 180 ml). Wide resections for malignant tumors were associated with significantly more blood loss than marginal resections for benign ones. Resections of bone tumors were accompanied by significantly more blood loss than those of soft tissue tumors. Overall, blood transfusions were required after 210 (20.1%) operations. Conclusions: Our results provide the first exhaustive data about blood loss and the subsequent need for transfusion associated with various kinds of musculoskeletal tumor surgeries that may be helpful for establishing a guideline for perioperative patient management.

Original languageEnglish
Pages (from-to)52-58
Number of pages7
JournalJournal of Surgical Oncology
Volume92
Issue number1
DOIs
Publication statusPublished - Oct 1 2005

Fingerprint

Blood Transfusion
Neoplasms
Operative Time
Bone and Bones
Disarticulation
Curettage
Amputation
Guidelines
Biopsy

Keywords

  • Blood loss
  • Bone and soft tissue tumor
  • Surgery
  • Transfusion

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Blood loss and transfusion associated with musculoskeletal tumor surgery. / Kawai, Akira; Kadota, Hiroaki; Yamaguchi, Umio; Morimoto, Yuki; Ozaki, Toshihumi; Beppu, Yasuo.

In: Journal of Surgical Oncology, Vol. 92, No. 1, 01.10.2005, p. 52-58.

Research output: Contribution to journalArticle

Kawai, A, Kadota, H, Yamaguchi, U, Morimoto, Y, Ozaki, T & Beppu, Y 2005, 'Blood loss and transfusion associated with musculoskeletal tumor surgery', Journal of Surgical Oncology, vol. 92, no. 1, pp. 52-58. https://doi.org/10.1002/jso.20375
Kawai, Akira ; Kadota, Hiroaki ; Yamaguchi, Umio ; Morimoto, Yuki ; Ozaki, Toshihumi ; Beppu, Yasuo. / Blood loss and transfusion associated with musculoskeletal tumor surgery. In: Journal of Surgical Oncology. 2005 ; Vol. 92, No. 1. pp. 52-58.
@article{f79d5d51009545f5acb1a3fc2c4aba3e,
title = "Blood loss and transfusion associated with musculoskeletal tumor surgery",
abstract = "Background and Objectives: No organized data regarding the blood losses associated with musculoskeletal tumor surgery has been existed. The present study aimed to examine the extent of blood loss and the transfusion requirement associated with various kinds of musculoskeletal tumor surgeries in a large, well-defined sample. Methods: The records of 1,047 consecutive operations for musculoskeletal tumors were reviewed. Results: The total blood loss ranged from 0 to 26,050 ml (median: 95 ml). The operative time ranged from 5 to 1,140 min (median: 105 min). There was a significant correlation between the total blood loss and the operative time. The median blood loss was 10 ml in biopsies, 100 ml in curettages, 190 ml in amputations or disarticulations, 30 ml in marginal resections (bone tumors, 50 ml; soft tissue tumors, 25 ml), and 380 ml in wide resections (bone tumors, 2,155 ml; soft tissue tumors, 180 ml). Wide resections for malignant tumors were associated with significantly more blood loss than marginal resections for benign ones. Resections of bone tumors were accompanied by significantly more blood loss than those of soft tissue tumors. Overall, blood transfusions were required after 210 (20.1{\%}) operations. Conclusions: Our results provide the first exhaustive data about blood loss and the subsequent need for transfusion associated with various kinds of musculoskeletal tumor surgeries that may be helpful for establishing a guideline for perioperative patient management.",
keywords = "Blood loss, Bone and soft tissue tumor, Surgery, Transfusion",
author = "Akira Kawai and Hiroaki Kadota and Umio Yamaguchi and Yuki Morimoto and Toshihumi Ozaki and Yasuo Beppu",
year = "2005",
month = "10",
day = "1",
doi = "10.1002/jso.20375",
language = "English",
volume = "92",
pages = "52--58",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Blood loss and transfusion associated with musculoskeletal tumor surgery

AU - Kawai, Akira

AU - Kadota, Hiroaki

AU - Yamaguchi, Umio

AU - Morimoto, Yuki

AU - Ozaki, Toshihumi

AU - Beppu, Yasuo

PY - 2005/10/1

Y1 - 2005/10/1

N2 - Background and Objectives: No organized data regarding the blood losses associated with musculoskeletal tumor surgery has been existed. The present study aimed to examine the extent of blood loss and the transfusion requirement associated with various kinds of musculoskeletal tumor surgeries in a large, well-defined sample. Methods: The records of 1,047 consecutive operations for musculoskeletal tumors were reviewed. Results: The total blood loss ranged from 0 to 26,050 ml (median: 95 ml). The operative time ranged from 5 to 1,140 min (median: 105 min). There was a significant correlation between the total blood loss and the operative time. The median blood loss was 10 ml in biopsies, 100 ml in curettages, 190 ml in amputations or disarticulations, 30 ml in marginal resections (bone tumors, 50 ml; soft tissue tumors, 25 ml), and 380 ml in wide resections (bone tumors, 2,155 ml; soft tissue tumors, 180 ml). Wide resections for malignant tumors were associated with significantly more blood loss than marginal resections for benign ones. Resections of bone tumors were accompanied by significantly more blood loss than those of soft tissue tumors. Overall, blood transfusions were required after 210 (20.1%) operations. Conclusions: Our results provide the first exhaustive data about blood loss and the subsequent need for transfusion associated with various kinds of musculoskeletal tumor surgeries that may be helpful for establishing a guideline for perioperative patient management.

AB - Background and Objectives: No organized data regarding the blood losses associated with musculoskeletal tumor surgery has been existed. The present study aimed to examine the extent of blood loss and the transfusion requirement associated with various kinds of musculoskeletal tumor surgeries in a large, well-defined sample. Methods: The records of 1,047 consecutive operations for musculoskeletal tumors were reviewed. Results: The total blood loss ranged from 0 to 26,050 ml (median: 95 ml). The operative time ranged from 5 to 1,140 min (median: 105 min). There was a significant correlation between the total blood loss and the operative time. The median blood loss was 10 ml in biopsies, 100 ml in curettages, 190 ml in amputations or disarticulations, 30 ml in marginal resections (bone tumors, 50 ml; soft tissue tumors, 25 ml), and 380 ml in wide resections (bone tumors, 2,155 ml; soft tissue tumors, 180 ml). Wide resections for malignant tumors were associated with significantly more blood loss than marginal resections for benign ones. Resections of bone tumors were accompanied by significantly more blood loss than those of soft tissue tumors. Overall, blood transfusions were required after 210 (20.1%) operations. Conclusions: Our results provide the first exhaustive data about blood loss and the subsequent need for transfusion associated with various kinds of musculoskeletal tumor surgeries that may be helpful for establishing a guideline for perioperative patient management.

KW - Blood loss

KW - Bone and soft tissue tumor

KW - Surgery

KW - Transfusion

UR - http://www.scopus.com/inward/record.url?scp=26244445212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26244445212&partnerID=8YFLogxK

U2 - 10.1002/jso.20375

DO - 10.1002/jso.20375

M3 - Article

C2 - 16180233

AN - SCOPUS:26244445212

VL - 92

SP - 52

EP - 58

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 1

ER -